Jane Street’s T2 Biosystems, Inc TTOO Stock Holding History

Jane Street’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4	Closed	-$10K	–	11230
2021 Q4	$10K	Hold	4	–	–	﹤0.01%	9907
2021 Q3	$19K	Buy	+4	New	+$20.1K	﹤0.01%	9751

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Jane Street's TTOO Position: Q1 2024 in Review

Jane Street sold out of T2 Biosystems, Inc (TTOO) in Q1 2024, closing a stake of 15,417 shares — an estimated $96.7K sold.

Jane Street first reported a position in TTOO in Q4 2018 and held it in 10 quarters. The position peaked at $316K in Q2 2019. 19 funds tracked by Wall St. Rank hold TTOO as of Q1 2024.

Jane Street reported no remaining T2 Biosystems, Inc position as of Q1 2024 after selling out during the quarter.
Jane Street sold 15,417 T2 Biosystems, Inc shares in Q1 2024, an estimated $96.7K.
Jane Street first reported a position in T2 Biosystems, Inc in Q4 2018 and held it in 10 quarters.
Jane Street's T2 Biosystems, Inc position peaked at $316K in Q2 2019.
19 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.